首页> 美国卫生研究院文献>other >Different Contributions of Clathrin- and Caveolae-Mediated Endocytosis of Vascular Endothelial Cadherin to Lipopolysaccharide-Induced Vascular Hyperpermeability
【2h】

Different Contributions of Clathrin- and Caveolae-Mediated Endocytosis of Vascular Endothelial Cadherin to Lipopolysaccharide-Induced Vascular Hyperpermeability

机译:网格蛋白和小窝介导的血管内皮钙黏着蛋白内吞作用对脂多糖诱导的血管通透性的不同贡献

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Vascular hyperpermeability induced by lipopolysaccharide (LPS) is a common pathogenic process in cases of severe trauma and sepsis. Vascular endothelial cadherin (VE-cad) is a key regulatory molecule involved in this process, although the detailed mechanism through which this molecule acts remains unclear. We assessed the role of clathrin-mediated and caveolae-mediated endocytosis of VE-cad in LPS-induced vascular hyperpermeability in the human vascular endothelial cell line CRL-2922 and determined that vascular permeability and VE-cad localization at the plasma membrane were negatively correlated after LPS treatment. Additionally, the loss of VE-cad at the plasma membrane was caused by both clathrin-mediated and caveolae-mediated endocytosis. Clathrin-mediated endocytosis was dominant early after LPS treatment, and caveolae-mediated endocytosis was dominant hours after LPS treatment. The caveolae-mediated endocytosis of VE-cad was activated through the LPS-Toll-like receptor 4 (TLR4)-Src signaling pathway. Structural changes in the actin cytoskeleton, specifically from polymerization to depolymerization, were important reasons for the switching of the VE-cad endocytosis pathway from clathrin-mediated to caveolae-mediated. Our findings suggest that clathrin-mediated and caveolae-mediated endocytosis of VE-cad contribute to LPS-induced vascular hyperpermeability, although they contribute via different mechanism. The predominant means of endocytosis depends on the time since LPS treatment.
机译:脂多糖(LPS)诱导的血管通透性过高是严重创伤和败血症的常见致病过程。血管内皮钙黏着蛋白(VE-cad)是参与此过程的关键调控分子,尽管该分子发挥作用的详细机制仍不清楚。我们评估了网格蛋白和小窝介导的VE-cad内吞作用在LPS诱导的人血管内皮细胞系CRL-2922的LPS诱导的血管通透性过高中的作用,并确定血管通透性和VE-cad在质膜上的定位呈负相关LPS治疗后。另外,质膜介导的和胞膜内膜介导的胞吞作用均引起质膜上VE-cad的损失。 LPS治疗后,网格蛋白介导的内吞作用占主导地位,LPS治疗后数小时,小窝介导的内吞作用占主导地位。 VE-cad的小窝介导的内吞作用通过LPS-Toll样受体4(TLR4)-Src信号传导途径激活。肌动蛋白细胞骨架的结构变化,特别是从聚合反应到解聚反应,是VE-cad内吞途径从网格蛋白介导的转化为小窝介导的重要原因。我们的研究结果表明,尽管网格蛋白通过不同的机制起作用,但是网格蛋白介导的和海绵体介导的VE-cad内吞作用有助于LPS诱导的血管通透性过高。内吞作用的主要手段取决于LPS治疗后的时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号